ciclopirox shampoo
teligent pharma, inc. - ciclopirox (unii: 19w019zdrj) (ciclopirox - unii:19w019zdrj) - none. teratogenic effects: pregnancy category b there are no adequate or well-controlled studies in pregnant women. therefore, ciclopirox shampoo should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. oral embryofetal developmental studies were conducted in mice, rats, rabbits and monkeys. ciclopirox or ciclopirox olamine was orally administered during the period of organogenesis. no maternal toxicity, embryotoxicity or teratogenicity were noted at the highest doses of 77, 125, 80 and 38.5 mg/kg/day ciclopirox in mice, rats, rabbits and monkeys, respectively (approximately 13, 42, 54 and 26 times the maximum recommended human dose based on body surface area comparisons, respectively). dermal embryofetal developmental studies were conducted in rats and rabbits with ciclopirox olamine dissolved in peg 400. ciclopirox olamine was topically administered during the period of organogenesis. no maternal toxicity, embryotoxicity or teratogenicity were noted at the hig
batrafen nail lacquer
pharma shalom - ciclopirox - lacque - ciclopirox 80 mg/g - ciclopirox - ciclopirox - for the treatment of fungal infections of the nails.
mycosten 10 mg/g cream
pierre fabre benelux sa-nv - ciclopirox olamine 1 g/100 g - cream - 10 mg/g - ciclopirox olamine 10 mg/g - ciclopirox
ciclopirox 0.77% / salicylic acid 2% shampoo
sincerus florida, llc - ciclopirox olamine (unii: 50md4sb4ap) (ciclopirox - unii:19w019zdrj), salicylic acid (unii: o414pz4lpz) (salicylic acid - unii:o414pz4lpz) -
ciclopirox 3% / itraconazole 5% / urea 20% cream
sincerus florida, llc - ciclopirox olamine (unii: 50md4sb4ap) (ciclopirox - unii:19w019zdrj), itraconazole (unii: 304nug5gf4) (itraconazole - unii:304nug5gf4), urea (unii: 8w8t17847w) (urea - unii:8w8t17847w) -
ciclopirox 3% gel
sincerus florida, llc - ciclopirox olamine (unii: 50md4sb4ap) (ciclopirox - unii:19w019zdrj) -
ciclopirox solution
nucare pharmaceuticals,inc. - ciclopirox (unii: 19w019zdrj) (ciclopirox - unii:19w019zdrj) - ciclopirox 80 mg in 1 ml - (to understand fully the indication for this product, please read the entire indications and usage section of the labeling.) ciclopirox topical solution, 8% as a component of a comprehensive management program, is indicated as topical treatment in immunocompetent patients with mild to moderate onychomycosis of fingernails and toenails without lunula involvement, due to trichophyton rubrum . the comprehensive management program includes removal of the unattached, infected nails as frequently as monthly, by a health care professional who has special competence in the diagnosis and treatment of nail disorders, including minor nail procedures. - no studies have been conducted to determine whether ciclopirox might reduce the effectiveness of systemic antifungal agents for onychomycosis. therefore, the concomitant use of 8% ciclopirox topical solution and systemic antifungal agents for onychomycosis, is not recommended. - ciclopirox topical solution, 8% should be used only under medical
loprox cream
bausch health, canada inc. - ciclopirox olamine - cream - 1% - ciclopirox olamine 1% - hydroxypyridones
loprox lotion
bausch health, canada inc. - ciclopirox olamine - lotion - 1% - ciclopirox olamine 1% - hydroxypyridones
mycoster 8 % nail lacquer
perrigo israel agencies ltd - ciclopirox - lacque - ciclopirox 8 %w/w - ciclopirox - treatment of fungal infections of the nails.